Page last updated: 2024-12-10

esculetin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

esculetin: used in filters for absorption of ultraviolet light; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

esculetin : A hydroxycoumarin that is umbelliferone in which the hydrogen at position 6 is substituted by a hydroxy group. It is used in filters for absorption of ultraviolet light. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281416
CHEMBL ID244743
CHEBI ID490095
SCHEMBL ID24641
MeSH IDM0050930

Synonyms (138)

Synonym
AC-18400
BRD-K58149231-001-06-9
ksc-11-243-1
KUC108669N
smr000059055
cichoriin aglucon
NSC26428 ,
esculetol
nsc-26428
6,7-dihydroxycoumarin
cichorigenin
esculatin
esculin aglucon
DIVK1C_006430
KBIO1_001374
NCI60_002119
SDCCGMLS-0066669.P001
brn 0152788
coumarin, 6,7-dihydroxy-
6,7-dihydroxy-2h-1-benzopyran-2-one
6,7-dihydroxy-2-benzopyrone
esculin aglycon
cichoriin aglycon
asculetine
nsc 26428
einecs 206-161-5
ccris 7065
SPECTRUM4_001886
SPECTRUM_001166
BSPBIO_002364
cas-305-01-1
NCGC00016425-01
PRESTWICK3_000940
PRESTWICK2_000940
BSPBIO_000880
SMP2_000093
inchi=1/c9h6o4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11
2h-1-benzopyran-2-one, 6,7-dihydroxy-
6,7-dihydroxy-2h-chromen-2-one
AB00489955
esculetin
305-01-1
C09263
aesculetin
BPBIO1_000968
OPREA1_719746
6,7-dihydroxycoumarin, 98%
NCGC00094873-02
NCGC00094873-01
MLS000069479 ,
KBIO2_004214
KBIO2_001646
KBIO3_001584
KBIOSS_001646
KBIO2_006782
KBIOGR_002416
PRESTWICK1_000940
SPECPLUS_000334
SPECTRUM3_000752
SPECTRUM2_000586
SPBIO_000432
PRESTWICK0_000940
SPBIO_003049
SPECTRUM1500899
SPECTRUM5_000512
NCGC00016425-02
E-3400
6,7-dihydroxy-1-benzopyran-2-one
6,7-dihydroxy-2-chromenone
AKOS000276955
CHEMBL244743 ,
E0386
HMS1570L22
HMS1921M14
chebi:490095 ,
HMS2097L22
6,7-dihydroxychromen-2-one
unii-sm2xd6v944
5-18-03-00202 (beilstein handbook reference)
sm2xd6v944 ,
A820407
BMSE000986
HMS2233G24
S4711
CCG-38509
NCGC00016425-06
NCGC00016425-04
NCGC00016425-03
NCGC00016425-05
91753-33-2
esculetin [inci]
esculetin [mi]
HMS3373K09
gtpl5180
FT-0620854
SCHEMBL24641
6,7-bis(oxidanyl)chromen-2-one
bdbm34571
cid_5281416
6,7-dihydroxy-2h-chromen-2-one #
ILEDWLMCKZNDJK-UHFFFAOYSA-N
AC-34573
E-3401
mfcd00006874
6,7-dihydroxycounmarin
DTXSID3075383
esculetin, analytical standard
SR-01000721907-2
sr-01000721907
esculetin, european pharmacopoeia (ep) reference standard
esculetol)
coumarin, 6,7-dihydroxy- esculetin
aesculetin (cichorigenin
2h-1-benzopyran-2-one, 6,7-dihydroxy- (9ci)
6,7-dihydroxy-coumarin
6,7-dihydroxycoumarin, 8ci
Q3058018
SY036794
2,6-dihydroxy-7h-chromen-7-one
cichorigenin|aesculetin
aesculetin ,(s)
AS-11863
STL560155
AMY25634
BRD-K58149231-001-10-1
A14553
BBL037229
esculetine
O11524
HY-N0284
CS-0008780
DTXSID801293090
2,6-dihydroxy-7h-1-benzopyran-7-one
HFC ,
EX-A6796
esculetin [matrix for maldi-tof/ms]
E1287
B0005-464319

Research Excerpts

Overview

Esculetin is a natural herbal compound used for the management of various diseases such as cardiovascular and renal disorders. It is mainly extracted from twig skin and the trunk bark of the Chinese herbal medicine Fraxinus rhynchophylla Hance. Esculetin has anti-oxidation and anti-inflammation bioactivities.

ExcerptReferenceRelevance
"Esculetin is a natural herbal compound used for the management of various diseases such as cardiovascular and renal disorders."( Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice.
Baluchnejadmojarad, T; Mohamadi-Zarch, SM; Nazari-Serenjeh, M; Nourabadi, D; Ramazi, S; Roghani, M, 2021
)
2.79
"Esculetin is a natural dihydroxy coumarin; it is mainly extracted from twig skin and the trunk bark of the Chinese herbal medicine Fraxinus rhynchophylla Hance. "( Esculetin: A review of its pharmacology and pharmacokinetics.
Li, X; Xie, Q; Zhang, L, 2022
)
3.61
"Esculetin is a bioactive compound of medicinal herb Hydrangea paniculata, and has showed anti-oxidation and anti-inflammation bioactivities. "( Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway.
Li, Z; Wang, J; Wu, H; Zhang, S; Zhang, Y, 2022
)
3.61
"Esculetin is a coumarin derivative, which is extracted from the dried barks of fraxinus chinensis Roxb. "( Antiovarian cancer mechanism of esculetin: inducing G0/G1 arrest and apoptosis via JAK2/STAT3 signalling pathway.
Cao, A; Chang, W; Fan, Z; Fu, X; Han, L; Meng, J; Ren, X; Yin, W; Zhou, S, 2023
)
2.64
"Esculetin is a coumarin-derived compound with antioxidant and anti-inflammatory properties. "( Effect of Esculetin on
Jung, WK; Kim, J; Kim, YH; Park, SB; Yu, HY, 2022
)
2.57
"Esculetin (ESC) is an active compound discovered in a variety of natural products that modulates a wide range of metabolic diseases and is a potential drug for the treatment of NAFLD."( Esculetin Alleviates Nonalcoholic Fatty Liver Disease on High-Cholesterol-Diet-Induced Larval Zebrafish and FFA-Induced BRL-3A Hepatocyte.
Deng, Y; Li, M; Ma, J; Shang, J; Yang, T, 2023
)
3.07
"Esculetin (ESC) is a coumarin with anti-inflammatory and anti-asthmatic effects."( Esculetin improves murine mastitis induced by streptococcus isolated from bovine mammary glands by inhibiting NF-κB and MAPK signaling pathways.
Gao, Y; Ge, B; Hao, Z; He, X; Liu, J; Su, Q; Tong, C; Wang, X; Wen, H; Zhang, H; Zhang, W; Zhou, G, 2023
)
3.07
"Esculetin is a type of natural coumarin that has many pharmacological activities such as antioxidant, anticancer, anti-inflammatory, etc."( Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis.
Cai, B; Cai, T, 2023
)
1.86
"Esculetin is an important bioactive coumarin with amazing potential to suppress the growth of cancer cells. "( In vitro anticancer effects of esculetin against human leukemia cell lines involves apoptotic cell death, autophagy, G0/G1 cell cycle arrest and modulation of Raf/MEK/ERK signalling pathway.
Liu, S; Wang, C; Wang, X; Yang, C; Zhang, Q; Zhang, X; Zhou, X,
)
1.86
"Esculetin is a polyphenolic compound found in many medicinal plants."( Esculetin and idebenone ameliorate galactose-induced cataract in a rat model.
Al-Hamid, HA; El-Boghdady, NA; Omar, NN; Sadik, NAH, 2020
)
2.72
"Esculetin is a 6,7 dihydroxy-coumarin obtained from various plant sources such as Aesculus hippocastanum L, Ceratostigma willmottianum, Citrus limonia, etc."( Protective Effect of Esculetin, Natural Coumarin in Mice Model of Fibromyalgia: Targeting Pro-Inflammatory Cytokines and MAO-A.
Bhatti, R; Garg, S; Kaur, A; Singh, AP; Singh, L, 2020
)
1.6
"Esculetin is a candidate urate-lowering drug with renoprotective activity and the ability to inhibit XO, promote excretion of UA, protect oxidative stress injury, and reduce renal fibrosis."( Multiple-Purpose Connectivity Map Analysis Reveals the Benefits of Esculetin to Hyperuricemia and Renal Fibrosis.
Huang, B; Kong, W; Meng, J; Wang, L; Wang, Y; Xie, Z; Yang, B; Zhang, T; Zhou, H, 2020
)
1.52
"Aesculetin is an active member of coumarins that has been reported to possess significant medicinal and biological importance. "( Naturally occurring aesculetin coumarin exerts antiproliferative effects in gastric cancer cells mediated via apoptotic cell death, cell cycle arrest and targeting PI3K/AKT/M-TOR signalling pathway.
Feng, M; Guan, W; Zhang, J, 2021
)
1.85
"Esculetin is a natural coumarin derivative from various plants with multiple pharmacological effects. "( Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence.
G V, NK; Kedam, T; Nelson, VK; Pullaiah, CP; Rayapu, S, 2021
)
2.33
"Esculetin is a polyphenolic compound with cytoprotective properties. "( Esculetin modulates cytotoxicity induced by oxidants in NB4 human leukemia cells.
Diez, JC; García-Pérez, AI; Herráez, A; Rubio, V; Tejedor, MC, 2017
)
3.34
"Esculetin is a natural coumarin derivative and has been reported to possess anti-allergic and anti-inflammatory effects."( Esculetin inhibits histamine-induced expression of inflammatory cytokines and mucin in nasal epithelial cells.
Sun, B; Wang, B; Xu, M, 2019
)
2.68
"Esculetin (ESC) is a natural coumarin that exhibits inspiring biological activities in a variety of animal models, but its neuroprotective effects on cerebral ischaemia have not been clearly elucidated."( Esculetin improves cognitive impairments induced by transient cerebral ischaemia and reperfusion in mice via regulation of mitochondrial fragmentation and mitophagy.
Chu, J; Deng, X; Fu, Q; Ma, S; Ma, Z; Wei, W; Xu, B; Zhu, L, 2019
)
2.68
"Esculetin is a coumarin derivative polyphenolic compound having diverse pharmacological and therapeutic properties."( Multi-spectroscopic and molecular modelling studies on the interaction of esculetin with calf thymus DNA.
Husain, MA; Ishqi, HM; Rehman, SU; Sarwar, T; Tabish, M, 2015
)
1.37
"Esculetin is a coumarin derivative from natural plants that has been commonly used as a folk medicine and has been reported to have beneficial pharmacological and biochemical activities; however, the mechanism by which esculetin prevents human gastric cancer cell growth is still largely unknown. "( Esculetin induces apoptosis in human gastric cancer cells through a cyclophilin D-mediated mitochondrial permeability transition pore associated with ROS.
He, L; Jiang, Y; Lv, W; Pan, H; Wang, BH, 2015
)
3.3
"Aesculetin (1) is an important coumarin found in various plant materials. "( Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells.
He, XR; Hu, XM; Qiu, GF; Xiao, YL; Yang, J, 2010
)
2.18
"Esculetin (ESC) is a coumarin that is present in several plants such as Fraxinus rhynchophylla and Artemisia capillaris. "( Esculetin ameliorates carbon tetrachloride-mediated hepatic apoptosis in rats.
Chang, WT; Chiu, CS; Huang, CY; Huang, TH; Liao, JC; Peng, WH; Tien, YC, 2011
)
3.25
"Esculetin is a phenolic compound that is found in various natural plant products and induces apoptosis in several types of human cancer cells. "( Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK.
Choi, BT; Choi, IW; Choi, YH; Jin, CY; Kim, GY; Kwon, TK; Lee, SJ; Lee, WH; Park, C, 2008
)
2.09

Effects

Esculetin has been shown to selectively induce tumor apoptosis in several types of cancers. It is regarded as a promising chemotherapeutic agent. Esculetin shows antiinflammatory action in animal models of asthma.

ExcerptReferenceRelevance
"Esculetin has shown antiinflammatory action in animal models of asthma; however, the effects of esculetin on ASMC phenotype switching have not been investigated."( Esculetin regulates the phenotype switching of airway smooth muscle cells.
Gao, J; Li, Y; Wang, Y; Xie, C, 2019
)
2.68
"Esculetin has been shown to selectively induce tumor apoptosis in several types of cancers and is regarded as a promising chemotherapeutic agent. "( Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells.
Chen, ML; Kok, SH; Kuo, MY; Yeh, CC, 2009
)
3.24

Actions

Esculetin tended to increase renal blood flow (RBF; 16 +/- 7%) and MLDF (28 +/- 13%) when given alone, but not when combined with ibuprofen. Esculetin did not inhibit interleukin-2 (IL-2) production, nor did it interfere with the appearance of IL-2 receptors on stimulated T cells.

ExcerptReferenceRelevance
"Esculetin plays an anti atherosclerotic role through reducing blood triglyceride level, preventing the proliferation of vascular smooth muscle cells (VSMC) and the production of matrix metallopeptidase 9 (MMP-9), inhibiting the oxidation of low density lipoprotein (LDL) and the secretion of adhesion factors and chemokines, and increasing the outflow level of high density lipoprotein cholesterol (HDL-C)."( Improvement effects of esculetin on the formation and development of atherosclerosis.
Jiang, JG; Qin, SW; Wang, QH, 2022
)
1.75
"Esculetin can increase bone mass by upregulating RANKL expression in osteoblasts and bone marrow stromal cells, and decreasing serum IL-6 concentration. "( Effect of esculetin on bone metabolism in ovariectomized rats.
Bai, D; Ju, D; Li, YBAJDL; Liu, H; Liu, L; Liu, M; Miao, Q; Pan, J; Sun, G; Wang, R; Wang, S; Wu, J, 2018
)
2.33
"Esculetin plays an inhibitory role in the growth of lung cancer by down-regulating c-myc, Cyclin D1 and NF-κB."( Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-κB.
Gu, J; Qian, H; Zhu, X, 2018
)
3.37
"Esculetin induced an increase in superoxide anion at long times of treatment and a reduction of peroxides at short times (1 h) with an observed increase at 2-4 h of treatment."( Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism.
Calviño, E; Diez, JC; García-Pérez, A; Herráez, A; Rubio, V, 2014
)
1.36
"Esculetin is known to inhibit tumor growth, but its effect in angiogenesis has not been studied. "( Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo.
Kim, WJ; Lee, SY; Moon, SK; Park, SL; Song, JH; Won, SY, 2016
)
3.32
"Esculetin tended to increase renal blood flow (RBF; 16 +/- 7%) and MLDF (28 +/- 13%) when given alone, but not when combined with ibuprofen."( Lipoxygenase and cyclo-oxygenase products in the control of regional kidney blood flow in rabbits.
Eppel, GA; Evans, RG; Oliver, JJ; Rajapakse, NW, 2003
)
1.04
"Esculetin did not inhibit interleukin-2 (IL-2) production, nor did it interfere with the appearance of IL-2 receptors on stimulated T cells, as judged by immunofluorescence using anti-Tac monoclonal antibody."( Esculetin inhibits T cell activation without suppressing IL-2 production or IL-2 receptor expression.
Al-Gorany, KH; Kabelitz, D, 1989
)
2.44

Treatment

Esculetin treatment significantly and dose-dependently upregulated the expression of E-cadherin mRNA (p < 0.05). Esculetin could improve phospho-FoxO1 expression, thus showing its ability to act on Akt/PI3K/FoxO 1 pathway. EsculetIn treatment significantly attenuates metabolic perturbations, alleviates insulin levels in hyperinsulinemic condition.

ExcerptReferenceRelevance
"Esculetin treatment significantly and dose-dependently upregulated the expression of E-cadherin mRNA (p < 0.05)."( Esculetin inhibits the proliferation of human lung cancer cells by targeting epithelial-to-mesenchymal transition of the cells.
Han, Z; Li, H; Wang, Q; Wang, Y; Xu, Z, 2019
)
2.68
"Esculetin treatment could improve phospho-FoxO1 expression, thus showing its ability to act on Akt/PI3K/FoxO1 pathway."( Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.
Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A; Raj, P; Sharma, N, 2017
)
2.62
"Esculetin treatment in both IR and T2D conditions substantially improved vascular reactivity, increased eNos and decreased Vcam1 mRNA levels, and reduced collagen deposition in rat thoracic aorta."( Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats.
Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V, 2017
)
2.62
"Esculetin treatment in LLC cells led to significant decrease of cell proliferation in a time- and dose-dependent manner. "( Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-κB.
Gu, J; Qian, H; Zhu, X, 2018
)
3.37
"Esculetin treatment significantly suppressed LPS-induced cell death mediated by apoptosis and necrosis in a concentration-dependent manner. "( Esculetin Protects Human Retinal Pigment Epithelial Cells from Lipopolysaccharide-induced Inflammation and Cell Death.
Erdogan, S; Guclu, H; Gurlu, V; Ozal, SA; Turkekul, K, 2018
)
3.37
"Esculetin treatment suppressed the histamine-induced p-p65 expression and p-IκBα degradation."( Esculetin inhibits histamine-induced expression of inflammatory cytokines and mucin in nasal epithelial cells.
Sun, B; Wang, B; Xu, M, 2019
)
2.68
"Esculetin treatment significantly attenuates metabolic perturbations, alleviates insulin levels in hyperinsulinemic condition."( Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia.
Bagal, S; Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A, 2015
)
2.58
"Esculetin treatment attenuated the increased immobility time and enhanced the diminished climbing time in the forced swim task elicited by acute restraint stress (ARS) in the 11- and 17-month-old mice versus their counterpart controls."( Age-dependent effects of esculetin on mood-related behavior and cognition from stressed mice are associated with restoring brain antioxidant status.
Benedí, J; Martín-Aragón, S; Villar, Á, 2016
)
1.46
"Esculetin treatment inhibited VEGF-induced proliferation and DNA synthesis of HUVECs with no cell toxicity."( Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo.
Kim, WJ; Lee, SY; Moon, SK; Park, SL; Song, JH; Won, SY, 2016
)
2.6
"Esculetin treatment in all three pancreatic cancer cell lines resulted in significant growth inhibition with G1-phase cell cycle arrest and induction of mitochondrial dependent apoptosis through activation of caspases 3, 8 and 9. "( Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.
Arora, R; Saini, V; Saluja, D; Sawney, S; Steffi, C; Tiwari, M, 2016
)
3.32
"Esculetin treatment in diabetic mice fed HFD significantly down-regulated expression of lipid synthesis genes (Fasn, Dgat2 and Plpp2) and inflammation genes (Tlr4, Myd88, Nfkb, Tnfα and Il6)."( Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
Choi, RY; Ham, JR; Lee, MK, 2016
)
2.6
"Esculetin treatment also activated extracellular signal‑regulated kinase (ERK), and pre‑treatment with PD98059, an ERK‑specific inhibitor, blocked esculetin-mediated phosphorylation of Nrf2 and the induction of NQO1 expression."( Cytoprotective effects of esculetin against oxidative stress are associated with the upregulation of Nrf2-mediated NQO1 expression via the activation of the ERK pathway.
Chae, JI; Choi, IW; Choi, SH; Choi, YH; Han, MH; Hong, SH; Kim, GY; Lee, DS; Park, C; Shim, JH; Yoo, YH, 2017
)
1.48
"Esculetin treatment also increased nuclear accumulation of Nrf2 by 8-fold indicating that increased NQO1 expression is Nrf2-mediated."( Esculetin-induced protection of human hepatoma HepG2 cells against hydrogen peroxide is associated with the Nrf2-dependent induction of the NAD(P)H: Quinone oxidoreductase 1 gene.
Ellis, EM; Subramaniam, SR, 2011
)
2.53
"Esculetin treatment attenuates the downregulation of PPARγ in diabetic kidney, which in turn blocks the TGF-β1-mediated fibronectin expression."( Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
Gupta, J; Surse, VM; Tikoo, K, 2011
)
2.53
"Esculetin treatment induced an increase in expression of Bax with a concomitant decrease of Bcl-2 in a time-dependent manner."( Esculetin induces mitochondria-mediated apoptosis in 3T3-L1 adipocytes.
Baile, CA; Della-Fera, MA; Yang, JY, 2006
)
2.5
"Pretreatment with esculetin significantly attenuated histopathological changes, inflammatory cell infiltration, and production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, in the lung tissue."( Esculetin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Modulation of the AKT/ERK/NF-κB and RORγt/IL-17 Pathways.
Chou, AH; Lee, HC; Liao, CC; Liu, FC; Tsai, CN; Yu, HP, 2020
)
2.32
"Treating aesculetin to mice alleviated PHMG-induced IL-8-mediated subepithelial fibrosis and airway barrier disruption."( Aesculetin Attenuates Alveolar Injury and Fibrosis Induced by Close Contact of Alveolar Epithelial Cells with Blood-Derived Macrophages via IL-8 Signaling.
Kang, MK; Kang, YH; Kim, DY; Kim, SI; Kim, YH; Lee, EJ; Na, W; Oh, H; Oh, SY, 2020
)
1.85
"Pre-treatment with esculetin for 28 days has significantly decreased the levels of cardiac bio-markers, lysosomal enzymes, membrane bound Na+ /K+ ATPase levels as well as Lipid peroxides which is in contrary to the ISO group."( Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence.
G V, NK; Kedam, T; Nelson, VK; Pullaiah, CP; Rayapu, S, 2021
)
1.21
"Treatment with esculetin effectively increased the phosphorylation of nuclear factor erythroid 2‑related factor 2 (Nrf2) and the expression of NAD(P)H:quinone oxidoreductase 1 (NQO1)."( Cytoprotective effects of esculetin against oxidative stress are associated with the upregulation of Nrf2-mediated NQO1 expression via the activation of the ERK pathway.
Chae, JI; Choi, IW; Choi, SH; Choi, YH; Han, MH; Hong, SH; Kim, GY; Lee, DS; Park, C; Shim, JH; Yoo, YH, 2017
)
1.09
"Pretreatment with esculetin (30-60 microM) was not able to reduce the contractile response induced by either carbachol (0.1 microM), histamine (10 microM), BaCl2 (10 mM) or K+ (80 mM)."( Effects of esculetin (6,7-dihydroxycoumarin) on guinea-pig tracheal chains in vitro.
Fassina, G; Froldi, G; Ragazzi, E,
)
0.84

Toxicity

ExcerptReferenceRelevance
" A single toxic dose of CCl(4) (1."( Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats.
Atmaca, M; Deniz Obay, B; Ketani, A; Murat Bilgin, H; Ozekinci, S; Taşdemir, E, 2011
)
0.37

Pharmacokinetics

ExcerptReferenceRelevance
" The underlining mechanisms of action and biological activities as well as the pharmacokinetic data of the analyzed compound reported so far are highlighted in this review with the aim of becoming a proven, and applicable insight and reference for further studies on the utilization of esculetin."( Esculetin: A review of its pharmacology and pharmacokinetics.
Li, X; Xie, Q; Zhang, L, 2022
)
2.34

Bioavailability

ExcerptReferenceRelevance
" The oral bioavailability of esculetin was shown by studies to be low."( Esculetin: A review of its pharmacology and pharmacokinetics.
Li, X; Xie, Q; Zhang, L, 2022
)
2.46
" The results highlight that the ELT obtained tremendous improvements in water solubility and bioavailability after cocrystal formation."( First cocrystal of esculetin: Simultaneously optimized in vitro/vivo properties and antioxidant effect.
Han, CB; Li, JY; Li, YT; Liu, F; Sun, WJ; Tong, SY; Wang, JH; Wang, XK, 2023
)
1.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
ultraviolet filterA photochemical role realized in the absorption of ultraviolet light, for example to protect skin cells from damage.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
simple coumarins biosynthesis2221
simplecoumarins biosynthesis620
coumarins biosynthesis (engineered)628
cichoriin interconversion013
esculetin modification219
superpathway of scopolin and esculin biosynthesis127
esculetin biosynthesis07
esculetin biosynthesis19
coumarins biosynthesis (engineered)831
esculetin modification221
superpathway of scopolin and esculin biosynthesis131
simple coumarins biosynthesis2823

Protein Targets (75)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency13.53830.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency16.76580.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency16.76580.025120.237639.8107AID886; AID893
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency4.46680.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency23.67560.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency23.35075.623417.292931.6228AID485281
thioredoxin reductaseRattus norvegicus (Norway rat)Potency67.83350.100020.879379.4328AID588453; AID588456
15-lipoxygenase, partialHomo sapiens (human)Potency10.00000.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency45.85770.141337.9142100.0000AID1490
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency24.84860.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency22.38720.180013.557439.8107AID1460
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency17.78280.707912.194339.8107AID720542
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency24.41520.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency10.00000.00137.762544.6684AID914; AID915
glucocerebrosidaseHomo sapiens (human)Potency28.18380.01268.156944.6684AID2101
alpha-galactosidaseHomo sapiens (human)Potency27.85254.466818.391635.4813AID1467; AID2107
IDH1Homo sapiens (human)Potency29.09290.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency79.43280.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency50.11870.016525.307841.3999AID602332
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency25.75740.036619.637650.1187AID1466; AID2100; AID2242
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency24.64400.001815.663839.8107AID894
importin subunit beta-1 isoform 1Homo sapiens (human)Potency62.30325.804836.130665.1308AID540253; AID540263
snurportin-1Homo sapiens (human)Potency62.30325.804836.130665.1308AID540253; AID540263
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency35.48135.804816.996225.9290AID540253
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency79.43280.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency5.01190.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency5.01190.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency5.01190.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency14.90040.004611.374133.4983AID624296; AID624297
DNA polymerase kappa isoform 1Homo sapiens (human)Potency3.10800.031622.3146100.0000AID588579
survival motor neuron protein isoform dHomo sapiens (human)Potency11.22020.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency25.11890.00419.962528.1838AID2675
caspase-1 isoform alpha precursorHomo sapiens (human)Potency7.50590.000311.448431.6228AID900
lethal factor (plasmid)Bacillus anthracis str. A2012Potency12.58930.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency11.22020.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency35.48133.548118.039535.4813AID1466
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Potency35.48133.548118.039535.4813AID1466
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Caspase-7Homo sapiens (human)Potency5.96223.981118.585631.6228AID889
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
MPI proteinHomo sapiens (human)IC50 (µMol)50.00000.190013.825650.1000AID1209; AID1220
M17 leucyl aminopeptidasePlasmodium falciparum 3D7IC50 (µMol)35.30000.410025.662546.3400AID588679
M18 aspartyl aminopeptidasePlasmodium falciparum 3D7IC50 (µMol)44.19000.385113.0782100.0000AID588678
M1-family alanyl aminopeptidasePlasmodium falciparum 3D7IC50 (µMol)48.200013.970031.085048.2000AID588680
Carbonic anhydrase 12Homo sapiens (human)Ki0.00930.00021.10439.9000AID1348314
Carbonic anhydrase 1Homo sapiens (human)Ki10.00000.00001.372610.0000AID1348311
Carbonic anhydrase 2Homo sapiens (human)Ki10.00000.00000.72369.9200AID1348312
Macrophage migration inhibitory factorHomo sapiens (human)IC50 (µMol)211.00000.03803.09109.8000AID1877334
Macrophage migration inhibitory factorHomo sapiens (human)Ki184.00000.03802.22565.5500AID1877338
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)67.20000.00101.191310.0000AID516862
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)57.00000.00021.557410.0000AID403341
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)8.20000.00132.81389.8200AID294445
Beta-secretase 1Homo sapiens (human)IC50 (µMol)500.00000.00061.619410.0000AID637774
Sorbitol dehydrogenaseHomo sapiens (human)IC50 (µMol)82.90000.24000.49531.0000AID516864
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)IC50 (µMol)8.77000.00442.923510.0000AID1701173
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)Ki1.49000.00101.46539.5400AID1701173
Carbonic anhydrase 9Homo sapiens (human)Ki0.03640.00010.78749.9000AID1348313
large T antigenBetapolyomavirus macacaeIC50 (µMol)25.94000.160024.9724100.0000AID1903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ERAP1 proteinHomo sapiens (human)AC509.72000.73006.753312.1400AID743314
ERAP2 proteinHomo sapiens (human)AbsAC200_uM3.27000.67802.19763.2700AID743319
leucyl-cystinyl aminopeptidase [Mus musculus]Mus musculus (house mouse)AbsAC200_uM2.12000.34801.13582.1200AID743339
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (147)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
prostaglandin biosynthetic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cytokine productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of mature B cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
inflammatory responseMacrophage migration inhibitory factorHomo sapiens (human)
cell surface receptor signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of gene expressionMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of protein kinase A signalingMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of macrophage chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
carboxylic acid metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cell migrationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of B cell proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of tumor necrosis factor productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of myeloid cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
regulation of macrophage activationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
innate immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of fibroblast proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of protein metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of prostaglandin secretion involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of myeloid leukocyte cytokine production involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
protein homotrimerizationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of arachidonic acid secretionMacrophage migration inhibitory factorHomo sapiens (human)
cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
glucose metabolic processSorbitol dehydrogenaseHomo sapiens (human)
sorbitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
glucuronate catabolic process to xylulose 5-phosphateSorbitol dehydrogenaseHomo sapiens (human)
flagellated sperm motilitySorbitol dehydrogenaseHomo sapiens (human)
fructose biosynthetic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol metabolic processSorbitol dehydrogenaseHomo sapiens (human)
DNA damage responseInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to cytokineInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cell fate determinationInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of autophagyInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cellular homeostasisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transportInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of anoikisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial fusionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
release of cytochrome c from mitochondriaInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (62)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
protease bindingMacrophage migration inhibitory factorHomo sapiens (human)
dopachrome isomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine receptor bindingMacrophage migration inhibitory factorHomo sapiens (human)
protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
chemoattractant activityMacrophage migration inhibitory factorHomo sapiens (human)
identical protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
phenylpyruvate tautomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
(R,R)-butanediol dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
L-iditol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
zinc ion bindingSorbitol dehydrogenaseHomo sapiens (human)
carbohydrate bindingSorbitol dehydrogenaseHomo sapiens (human)
identical protein bindingSorbitol dehydrogenaseHomo sapiens (human)
D-xylulose reductase activitySorbitol dehydrogenaseHomo sapiens (human)
D-sorbitol dehydrogenase (acceptor) activitySorbitol dehydrogenaseHomo sapiens (human)
ribitol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
NAD bindingSorbitol dehydrogenaseHomo sapiens (human)
protein bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transporter activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein heterodimerization activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH3 domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
channel activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (47)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular regionMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
nucleoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytosolMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneMacrophage migration inhibitory factorHomo sapiens (human)
cell surfaceMacrophage migration inhibitory factorHomo sapiens (human)
vesicleMacrophage migration inhibitory factorHomo sapiens (human)
secretory granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular exosomeMacrophage migration inhibitory factorHomo sapiens (human)
ficolin-1-rich granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
extracellular spaceSorbitol dehydrogenaseHomo sapiens (human)
cytosolSorbitol dehydrogenaseHomo sapiens (human)
membraneSorbitol dehydrogenaseHomo sapiens (human)
motile ciliumSorbitol dehydrogenaseHomo sapiens (human)
mitochondrial membraneSorbitol dehydrogenaseHomo sapiens (human)
extracellular exosomeSorbitol dehydrogenaseHomo sapiens (human)
nucleusInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytosolInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
Bcl-2 family protein complexInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (98)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID315164Cytotoxicity against human U937 cells by trypan blue assay after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID1105460Antifungal activity against Aspergillus fumigatus IPP 210 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID637775Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID398955Antitumor activity against Agrobacterium tumefaciens-induced tumor formation at 10 ug/disk by potato disk assay
AID1105461Antifungal activity against Aspergillus fumigatus ATCC 16913 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1105455Antifungal activity against Aspergillus flavus LM 210 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID715801Cell cycle arrest in human U937 cells assessed as accumulation at sub-G0/G1 phase at 250 uM after 24 hrs using propidium iodide staining by FACS analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID398956Cytotoxicity against mouse 9PS cells
AID1348314Inhibition of human carbonic anhydrase 12 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID333331Induction of strand scission in pBR322 DNA assessed as conversion from supercoiled form to nicked form at 100 uM after 60 mins by agarose gel electrophoresis in presence of Cu2+2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID1348311Inhibition of human carbonic anhydrase 1 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID333334Induction of strand scission in supercoiled pBR322 DNA by agarose gel electrophoresis in presence of Fe2+2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID516866Selectivity index, ratio of IC50 for human recombinant aldose reductase 1 to IC50 for kidney aldose reductase 22010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID715775Induction of free radicals production in RPMI 1640 medium at pH 7.4 by electron spin resonance analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID398948Antitumor activity against mouse 3PS cells xenografted mouse assessed as increase in life span
AID315166Induction of DNA fragmentation in human U937 cells at 2 mM after 24 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID744452Inhibition of mouse brain monoamine oxidase using kynuramine as substrate by fluorometric analysis2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
AID541339Inhibition of alpha-glucosidase at 200 uM using para-nitrophenyl substrate2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors.
AID1877336Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability up to 100 uM by CCK8 assay2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID516863Inhibition kidney aldose reductase 2 by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1717721Inhibition of mushroom tyrosinase using L-tyrosine as substrate2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
AID683689Cytotoxicity against human U138MG cells incubated for 48 hrs by MTT assay2012European journal of medicinal chemistry, Nov, Volume: 57Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon species.
AID1138893Antiasthamic activity in Wistar rat tracheal ring assessed as reversal of carbachol-induced contraction at 0.1 to 500 uM relative to control2014European journal of medicinal chemistry, Apr-22, Volume: 77Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
AID624607Specific activity of expressed human recombinant UGT1A32000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1348313Inhibition of human carbonic anhydrase 9 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID315168Induction of apoptosis in human U937 cells at 250 uM after 24 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID355096Antiinflammatory activity in NMRI mouse macrophages assessed as inhibition of A23187-induced LTC4 release at 25 uM by Ellman's method relative to control1996Journal of natural products, Dec, Volume: 59, Issue:12
Antiinflammatory activity of coumarins from Santolina oblongifolia.
AID355094Antiinflammatory activity in NMRI mouse macrophages assessed as inhibition of A23187-induced PGE2 release at 100 uM by Ellman's method relative to control1996Journal of natural products, Dec, Volume: 59, Issue:12
Antiinflammatory activity of coumarins from Santolina oblongifolia.
AID715790Induction of apoptosis in human U937 cells assessed as active 11 kDa fragment of caspase-3 at 250 uM after 24 hrs by Western blot analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1105458Antifungal activity against Aspergillus fumigatus ATCC 40640 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID683688Cytotoxicity against rat C6 cells incubated for 48 hrs by MTT assay2012European journal of medicinal chemistry, Nov, Volume: 57Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon species.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1877332Potency index ratio of ISO-1 IC50 to test compound IC50 for inhibition of MIF tautomerase (unknown origin) using 4-HPP as substrate2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID426927Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay2009Journal of natural products, Jun, Volume: 72, Issue:6
7-O-methylkaempferol and -quercetin glycosides from the whole plant of Nervilia fordii.
AID1105456Antifungal activity against Aspergillus flavus ATCC 16013 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1349248Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition2017Journal of natural products, 12-22, Volume: 80, Issue:12
Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities.
AID516864Inhibition sorbitol dehydrogenase by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1701173Displacement of FAM-Bid peptide from recombinant N-terminal His6x-tagged human Mcl-1 expressed in Escherichia coli BL21 (DE3) incubated for 30 mins by fluorescence polarization assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
AID516865Selectivity index, ratio of IC50 for sorbitol dehydrogenase to IC50 for kidney aldose reductase 22010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1105457Antifungal activity against Aspergillus flavus LM 247 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1105459Antifungal activity against Aspergillus fumigatus ATCC 46913 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID315165Growth inhibition of human U937 cells by [3H]thymidine incorporation assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID333327Induction of strand scission in pBR322 DNA assessed as conversion from supercoiled form to nicked form at 250 uM after 60 mins by agarose gel electrophoresis in absence of Cu2+2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID333332Induction of strand scission in pBR322 DNA assessed as conversion from supercoiled form to nicked form at 50 uM after 60 mins by agarose gel electrophoresis in presence of Cu2+2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID294445Inhibition of xanthine oxidase2007European journal of medicinal chemistry, Jul, Volume: 42, Issue:7
Relationship between quantum-chemical descriptors of proton dissociation and experimental acidity constants of various hydroxylated coumarins. Identification of the biologically active species for xanthine oxidase inhibition.
AID428403Cytoprotective activity against linoleic acid hydroperoxide-induced toxicity in HUVEC cells after 3 hrs2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Investigation of the antioxidant properties of some new 4-hydroxycoumarin derivatives.
AID1138894Antiasthamic activity in Wistar rat tracheal ring assessed as reversal of carbachol-induced contraction2014European journal of medicinal chemistry, Apr-22, Volume: 77Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
AID333330Induction of strand scission in pBR322 DNA assessed as conversion from supercoiled form to nicked form at 250 uM after 60 mins by agarose gel electrophoresis in presence of Cu2+2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID637774Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1328524Gastroprotective activity in Swiss albino mouse assessed as reduction in HCl/EtOH-induced gastric lesions at 20 mg/kg, po pretreated for 50 mins followed by HCl/EtOH challenge measured after 1 hr2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Gastroprotective activity of synthetic coumarins: Role of endogenous prostaglandins, nitric oxide, non-protein sulfhydryls and vanilloid receptors.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID715800Inhibition of clonogenic activity in human U937 cells assessed as reduction of colony formation in soft agar at 100 to 250 uM after 24 hrs using crystal violet staining2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1877335Reversal inhibition of MIF tautomerase (unknown origin) at 0.5 mM using 4-HPP as substrate preincubated for 30 min followed by 100 fold dilution by dilution assay2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID383183Inhibition of Saccharomyces sp. alpha-glucosidase2008Journal of natural products, May, Volume: 71, Issue:5
alpha-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus.
AID715792Induction of apoptosis in human U937 cells assessed as PARP cleavage at 250 uM after 24 hrs by Western blot analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715794Induction of apoptosis in human U937 cells assessed as activation of caspase-3 at 250 uM after 24 hrs by colorimetric assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1877334Inhibition of MIF tautomerase (unknown origin) using 4-HPP as substrate preincubated for 1 hr followed by substrate addition2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID1348312Inhibition of human carbonic anhydrase 2 incubated for 15 mins prior to testing by stopped-flow CO2 hydration assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
AID355098Antiinflammatory activity in NMRI mouse macrophages assessed as inhibition of A23187-induced LTC4 release by Ellman's method1996Journal of natural products, Dec, Volume: 59, Issue:12
Antiinflammatory activity of coumarins from Santolina oblongifolia.
AID516862Inhibition human recombinant aldose reductase 1 by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1877338Inhibition of MIF tautomerase (unknown origin) using 4-HPP as substrate preincubated for 1 hr followed by substrate addition by Lineweaver-Burk plot anlysis2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID1877333Inhibition of inhibition of MIF tautomerase (unknown origin) in MIF-induced mouse RAW264.7 cells assessed as reduction in cell migration relative to control2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID1248399Inhibition of alpha-amylase (unknown origin) relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID715805Induction of apoptosis in human U937 cells assessed as reduction of normal cells at 250 uM after 24 hrs by Annexin V-FITC double staining2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1105454Antifungal activity against Aspergillus flavus LM 26 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID715774Induction of free radicals production in carbonate buffer at pH 9 by electron spin resonance analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID426928Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as total inhibitory concentration after 3 days by plaque reduction assay2009Journal of natural products, Jun, Volume: 72, Issue:6
7-O-methylkaempferol and -quercetin glycosides from the whole plant of Nervilia fordii.
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID715803Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715802Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID333335Induction of strand scission in supercoiled pBR322 DNA by agarose gel electrophoresis in presence of added metal ion2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID1877340Non-competitive inhibition of MIF tautomerase (unknown origin) using 4-HPP as substrate preincubated for 1 hr followed by substrate addition by Lineweaver-Burk plot anlysis2022Bioorganic & medicinal chemistry letters, 01-01, Volume: 55Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.
AID398954Toxicity against brine shrimp
AID333333Induction of strand scission in supercoiled pBR322 DNA by agarose gel electrophoresis in presence of Cu2+2004Journal of natural products, Sep, Volume: 67, Issue:9
A coumarin from Mallotus resinosus that mediates DNA cleavage.
AID355097Antiinflammatory activity in NMRI mouse macrophages assessed as inhibition of A23187-induced PGE2 release by Ellman's method1996Journal of natural products, Dec, Volume: 59, Issue:12
Antiinflammatory activity of coumarins from Santolina oblongifolia.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (361)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (11.36)18.7374
1990's39 (10.80)18.2507
2000's84 (23.27)29.6817
2010's144 (39.89)24.3611
2020's53 (14.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.63 (24.57)
Research Supply Index5.94 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index91.11 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews12 (3.17%)6.00%
Case Studies2 (0.53%)4.05%
Observational0 (0.00%)0.25%
Other364 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]